These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31570139)

  • 41. Causal Modeling in WOC Nursing Research.
    Templin T; Pieper B
    J Wound Ostomy Continence Nurs; 2003 Jul; 30(4):168-74. PubMed ID: 12851591
    [No Abstract]   [Full Text] [Related]  

  • 42. A proposed clinical and biological interpretation of mediated interaction.
    Ikram MA; VanderWeele TJ
    Eur J Epidemiol; 2015 Oct; 30(10):1115-8. PubMed ID: 26438385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Some controversies in planning and analysing multi-centre trials.
    Senn S
    Stat Med; 1998 Aug 15-30; 17(15-16):1753-65; discussion 1799-800. PubMed ID: 9749445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conditional pairwise person parameter estimates in Rasch models.
    Kreiner S
    J Appl Meas; 2012; 13(4):314-20. PubMed ID: 23270977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The (mis)use of overlap of confidence intervals to assess effect modification.
    Knol MJ; Pestman WR; Grobbee DE
    Eur J Epidemiol; 2011 Apr; 26(4):253-4. PubMed ID: 21424218
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical interpretation of negative mediated interaction.
    Mutlu U; Ikram MA; Ikram MK
    Int J Epidemiol; 2019 Aug; 48(4):1286-1293. PubMed ID: 30508110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing moderated mediation in linear models requires fewer confounding assumptions than assessing mediation.
    Loeys T; Talloen W; Goubert L; Moerkerke B; Vansteelandt S
    Br J Math Stat Psychol; 2016 Nov; 69(3):352-374. PubMed ID: 27711981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpreting Violations of Falsification Tests in the Context of Multiple Proposed Instrumental Variables.
    Diemer EW
    Epidemiology; 2024 Sep; 35(5):638-641. PubMed ID: 38771710
    [No Abstract]   [Full Text] [Related]  

  • 49. The identification of synergism in the sufficient-component-cause framework.
    VanderWeele TJ; Robins JM
    Epidemiology; 2007 May; 18(3):329-39. PubMed ID: 17435441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Causal models adjusting for time-varying confounding-a systematic review of the literature.
    Clare PJ; Dobbins TA; Mattick RP
    Int J Epidemiol; 2019 Feb; 48(1):254-265. PubMed ID: 30358847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of unmeasured confounding on the MR Steiger approach.
    Lutz SM; Voorhies K; Wu AC; Hokanson J; Vansteelandt S; Lange C
    Genet Epidemiol; 2022 Mar; 46(2):139-141. PubMed ID: 35170805
    [No Abstract]   [Full Text] [Related]  

  • 52. Unmeasured Confounding in Observational Studies of Management of Cerebellar Intracranial Hemorrhage-Reply.
    Kuramatsu JB; Sheth KN; Huttner HB
    JAMA; 2020 Feb; 323(7):666. PubMed ID: 32068814
    [No Abstract]   [Full Text] [Related]  

  • 53. Flexible Mediation Analysis With Multiple Mediators.
    Steen J; Loeys T; Moerkerke B; Vansteelandt S
    Am J Epidemiol; 2017 Jul; 186(2):184-193. PubMed ID: 28472328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges in interpreting study results: the conflict between appearance and reality.
    Barnett ML; Hyman JJ
    J Am Dent Assoc; 2006 Oct; 137 Suppl():32S-36S. PubMed ID: 17012734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.
    Fang G; Brooks JM; Chrischilles EA
    Am J Epidemiol; 2012 Jan; 175(1):60-5. PubMed ID: 22085626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A general class of recapture models based on the conditional capture probabilities.
    Farcomeni A
    Biometrics; 2016 Mar; 72(1):116-24. PubMed ID: 26355633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uses of ecologic studies in the assessment of intended treatment effects.
    Wen SW; Kramer MS
    J Clin Epidemiol; 1999 Jan; 52(1):7-12. PubMed ID: 9973068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical power for nonequivalent pretest-posttest designs. The impact of change-score versus ANCOVA models.
    Oakes JM; Feldman HA
    Eval Rev; 2001 Feb; 25(1):3-28. PubMed ID: 11205523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Counterfactual prediction is not only for causal inference.
    Dickerman BA; Hernán MA
    Eur J Epidemiol; 2020 Jul; 35(7):615-617. PubMed ID: 32623620
    [No Abstract]   [Full Text] [Related]  

  • 60. Graphical presentation of confounding in directed acyclic graphs.
    Suttorp MM; Siegerink B; Jager KJ; Zoccali C; Dekker FW
    Nephrol Dial Transplant; 2015 Sep; 30(9):1418-23. PubMed ID: 25324358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.